1,1,3,3,3,3-Hexamethylindotricarbocyanineiodide

Catalog No. :
ACUKMQ583
CAS No. :
19764-96-6
Molecular Formula :
C29H33IN2
Molecular Weight :
536.50

IUPAC Name:1,3,3-trimethyl-2-(7-(1,3,3-trimethylindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3H-indol-1-ium iodide

1,1,3,3,3,3-Hexamethylindotricarbocyanineiodide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg95%$80.00Login to see priceInquiryInquiry
25mg95%$149.00Login to see priceInquiryInquiry
50mg95%$235.00Login to see priceInquiryInquiry
100mg95%$350.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,1,3,3,3,3-Hexamethylindotricarbocyanineiodide
IUPAC Name1,3,3-trimethyl-2-(7-(1,3,3-trimethylindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3H-indol-1-ium iodide
MDL No.MFCD00011950
Molecular FormulaC29H33IN2
Molecular Weight536.50
SMILESCC1(C)C(C=CC=CC=CC=C2N(C)C3=C(C=CC=C3)C2(C)C)=[N+](C)C4=C1C=CC=C4.[I-]
InChI KeyJKXWXYURKUEZHV-UHFFFAOYSA-M
Synonym19764-96-6 | 3H-Indolium, 2-[7-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1,3,5-heptatrienyl]-1,3,3-trimethyl-, iodide | 1,3,3-Trimethyl-2-[7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indole;iodide | 1,1',3,3,3',3'-Hexamethylindotricarbocy
CAS No.19764-96-6
PubChem CID89218

Synthetic Route by SureRoute

1. ACUKMQ583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUKMQ583 route product structure diagram
    ACUKMQ58319764-96-6
Inquiry

2. ACUKMQ583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUKMQ583 route product structure diagram
    ACUKMQ58319764-96-6
Inquiry

Comments (0)